Univariate analysis revealed that gender, histological grade, subsites, T stage, N stage AJCC stage, treatment modality, and FOXD1 expression level were associated with the overall survival of HNSCC patients (all p < 0.05, Table 2). The gene discussed is FOXD1; the disease is head and neck squamous cell carcinoma.